| scholarly article | Q13442814 |
| P50 | author | Luis Ángel Fernández | Q42770872 |
| David Ruano-Gallego | Q58239582 | ||
| P2093 | author name string | Beatriz Álvarez | |
| P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells | Q27028058 | ||
| The antigen 43 structure reveals a molecular Velcro-like mechanism of autotransporter-mediated bacterial clumping | Q27680876 | ||
| Structure of GrlR-GrlA complex that prevents GrlA activation of virulence genes | Q27686888 | ||
| Chaperone release and unfolding of substrates in type III secretion | Q28275782 | ||
| Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant | Q29615039 | ||
| The type III secretion injectisome | Q29617944 | ||
| Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria | Q30318075 | ||
| Programming controlled adhesion of E. coli to target surfaces, cells, and tumors with synthetic adhesins. | Q30643835 | ||
| Regulation of type III secretion systems | Q33337072 | ||
| Locus of enterocyte effacement-encoded regulator (Ler) of pathogenic Escherichia coli competes off histone-like nucleoid-structuring protein (H-NS) through noncooperative DNA binding | Q33619316 | ||
| Direct injection of functional single-domain antibodies from E. coli into human cells | Q33775617 | ||
| Bacterial delivery of nuclear proteins into pluripotent and differentiated cells | Q33815158 | ||
| A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells | Q33888663 | ||
| Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure | Q33944789 | ||
| A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspF. | Q34121443 | ||
| N-terminal type III secretion signal of enteropathogenic Escherichia coli translocator proteins | Q42713418 | ||
| Dynamics of expression and maturation of the type III secretion system of enteropathogenic Escherichia coli | Q42796756 | ||
| Role of periplasmic chaperones and BamA (YaeT/Omp85) in folding and secretion of intimin from enteropathogenic Escherichia coli strains | Q43071863 | ||
| The Escherichia coli common pilus and the bundle-forming pilus act in concert during the formation of localized adherence by enteropathogenic E. coli | Q43127737 | ||
| Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli | Q44038146 | ||
| Gene replacement without selection: regulated suppression of amber mutations in Escherichia coli | Q44508201 | ||
| PerC and GrlA independently regulate Ler expression in enteropathogenic Escherichia coli. | Q45944240 | ||
| Structure of the Escherichia coli FlhDC complex, a prokaryotic heteromeric regulator of transcription | Q46842233 | ||
| Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells | Q48042079 | ||
| The filamentous type III secretion translocon of enteropathogenic Escherichia coli | Q50112055 | ||
| The muramidase EtgA from enteropathogenic Escherichia coli is required for efficient type III secretion. | Q50548751 | ||
| Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector. | Q51125919 | ||
| CesT is a multi-effector chaperone and recruitment factor required for the efficient type III secretion of both LEE- and non-LEE-encoded effectors of enteropathogenic Escherichia coli. | Q54479840 | ||
| 3D structure of EspA filaments from enteropathogenic Escherichia coli. | Q54522745 | ||
| A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. | Q54574143 | ||
| Improving sequencing quality from PCR products containing long mononucleotide repeats | Q84457385 | ||
| Bacterial nanomachines: the flagellum and type III injectisome. | Q34142106 | ||
| Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements | Q34177961 | ||
| Intimin and the host cell--is it bound to end in Tir(s)? | Q34241197 | ||
| The GrlR-GrlA regulatory system coordinately controls the expression of flagellar and LEE-encoded type III protein secretion systems in enterohemorrhagic Escherichia coli | Q34976698 | ||
| Selection of single domain antibodies from immune libraries displayed on the surface of E. coli cells with two β-domains of opposite topologies | Q35005394 | ||
| Visualization of the type III secretion sorting platform of Shigella flexneri | Q35037858 | ||
| Outer membrane adhesion factor multivalent adhesion molecule 7 initiates host cell binding during infection by gram-negative pathogens. | Q35105253 | ||
| Bacterial delivery of TALEN proteins for human genome editing | Q35117894 | ||
| Citrobacter rodentium: infection, inflammation and the microbiota | Q35218043 | ||
| Characterization of EspC, a 110-kilodalton protein secreted by enteropathogenic Escherichia coli which is homologous to members of the immunoglobulin A protease-like family of secreted proteins | Q35616915 | ||
| Bioinformatics, genomics and evolution of non-flagellar type-III secretion systems: a Darwinian perspective | Q36088671 | ||
| Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens | Q36211798 | ||
| Role of EscP (Orf16) in injectisome biogenesis and regulation of type III protein secretion in enteropathogenic Escherichia coli | Q36363508 | ||
| Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein | Q36739956 | ||
| A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy. | Q36883886 | ||
| Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors. | Q36919064 | ||
| Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter | Q37008377 | ||
| Motility is critical for effective distribution and accumulation of bacteria in tumor tissue | Q37115798 | ||
| Type III protein secretion in plant pathogenic bacteria | Q37490586 | ||
| Controlling injection: regulation of type III secretion in enterohaemorrhagic Escherichia coli | Q37574604 | ||
| A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis | Q37690960 | ||
| The EspF effector, a bacterial pathogen's Swiss army knife | Q37777278 | ||
| Intimate host attachment: enteropathogenic and enterohaemorrhagic Escherichia coli | Q38127457 | ||
| Assembly of the bacterial type III secretion machinery. | Q38183945 | ||
| The cell death response to enteropathogenic Escherichia coli infection | Q38255302 | ||
| Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways | Q38318508 | ||
| Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. | Q39513282 | ||
| Escherichia coli K-12 possesses multiple cryptic but functional chaperone-usher fimbriae with distinct surface specificities. | Q39722282 | ||
| Markerless gene replacement in Escherichia coli stimulated by a double-strand break in the chromosome | Q39729563 | ||
| Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice | Q39814944 | ||
| Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome | Q39846433 | ||
| Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli | Q40426825 | ||
| Polarity of enteropathogenic Escherichia coli EspA filament assembly and protein secretion | Q40439695 | ||
| Enteropathogenic Escherichia coli (EPEC) adhesion to intestinal epithelial cells: role of bundle-forming pili (BFP), EspA filaments and intimin | Q40583582 | ||
| Ler is a negative autoregulator of the LEE1 operon in enteropathogenic Escherichia coli | Q40731104 | ||
| Role of EscF, a putative needle complex protein, in the type III protein translocation system of enteropathogenic Escherichia coli | Q40770368 | ||
| Combined inactivation and expression strategy to study gene function under physiological conditions: application to identification of new Escherichia coli adhesins | Q40946668 | ||
| Temporal expression of enteropathogenic Escherichia coli virulence genes in an in vitro model of infection | Q40991172 | ||
| Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. | Q41823804 | ||
| A sorting platform determines the order of protein secretion in bacterial type III systems | Q41876550 | ||
| Dynamics of the type III secretion system activity of enteropathogenic Escherichia coli. | Q41911503 | ||
| Transcriptional regulation of type III secretion genes in enteropathogenic Escherichia coli: Ler antagonizes H-NS-dependent repression | Q42641819 | ||
| The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. | Q42677853 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P921 | main subject | Escherichia coli K-12 | Q21399437 |
| P304 | page(s) | 1030-1041 | |
| P577 | publication date | 2015-05-27 | |
| P1433 | published in | ACS Synthetic Biology | Q4650828 |
| P1476 | title | Engineering the Controlled Assembly of Filamentous Injectisomes in E. coli K-12 for Protein Translocation into Mammalian Cells | |
| P478 | volume | 4 |
| Q36073419 | A part toolbox to tune genetic expression in Bacillus subtilis. |
| Q47097262 | Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors |
| Q46291702 | Citrobacter rodentium Subverts ATP Flux and Cholesterol Homeostasis in Intestinal Epithelial Cells In Vivo |
| Q37134828 | Engineering Salmonella as intracellular factory for effective killing of tumour cells. |
| Q64096526 | Enteropathogenic Escherichia coli Stimulates Effector-Driven Rapid Caspase-4 Activation in Human Macrophages |
| Q39235366 | Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome |
| Q38734240 | Intracellular delivery of biologic therapeutics by bacterial secretion systems. |
| Q26739702 | Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer |
| Q47399527 | Rationale redesign of type III secretion systems: toward the development of non-pathogenic E. coli for in vivo delivery of therapeutic payloads |
| Q96954783 | Small RNAs as Fundamental Players in the Transference of Information During Bacterial Infectious Diseases |
| Q40140126 | Sustainable therapies by engineered bacteria |
| Q28074332 | Type Three Secretion System in Attaching and Effacing Pathogens |
Search more.